首页>
外国专利>
DNA OLIGOMER, GENE MARKER AND DNA OLIGOMER SET FOR PREDICTING THE ONSET OF SIDE EFFECT IN RADIOTHERAPY AND METHOD OF PREDICTING THE ONSET OF SIDE EFFECT
DNA OLIGOMER, GENE MARKER AND DNA OLIGOMER SET FOR PREDICTING THE ONSET OF SIDE EFFECT IN RADIOTHERAPY AND METHOD OF PREDICTING THE ONSET OF SIDE EFFECT
It is intended to provide a DNA oligomer, a gene marker, a DNA oligomer set (a primer set for PCR) and a DNA oligomer (a primer for extension) whereby the risk of the onset of a side effect in a radiotherapy for cancer can be predicted by judging whether a specific base in a DNA base sequence is a risk allele or a non-risk allele; and a method of predicting the onset of a side effect in a radiotherapy. The above-described DNA oligomer for predicting the onset of a side effect in a radiotherapy has a DNA sequence having at least 10 to 241 consecutive bases including the base at the 121-position in a DNA base sequence represented by any one of SEQ ID NOS:1 to 173 in Sequence Listing.
展开▼
机译:旨在提供DNA寡聚体,基因标记,DNA寡聚体组(用于PCR的引物组)和DNA寡聚体(用于延伸的引物),由此可以在癌症的放射疗法中产生副作用的风险。通过判断DNA碱基序列中的特定碱基是风险等位基因还是非风险等位基因来预测;和预测放疗中副作用发作的方法。上述用于预测放射治疗中副作用发生的DNA低聚物的DNA序列具有至少10至241个连续的碱基,包括SEQ ID NOS所示的DNA碱基序列中121位的碱基。序列表中的1到173。
展开▼